How should spirometry with a forced expiratory volume in one second/forced vital capacity ratio of 67%, a forced expiratory volume in one second of 55% predicted, and a forced vital capacity of 82% predicted be interpreted and managed?

Moderate COPD with Airflow Obstruction

These spirometry values confirm COPD with moderate airflow obstruction (GOLD Grade 2), requiring initiation of bronchodilator therapy and comprehensive management including smoking cessation if applicable.

Spirometry Interpretation

Your results show:

• FEV1/FVC ratio of 67% (below the 0.7 threshold) = confirms airflow obstruction 1, 2
• FEV1 of 55% predicted = moderate severity obstruction (GOLD Grade 2: 50-79% predicted)
• FVC of 82% predicted = relatively preserved lung volumes

Key Diagnostic Points

The FEV1/FVC ratio <0.7 is the critical diagnostic criterion. According to the most recent GOLD 2025 guidelines, post-bronchodilator spirometry should be used to confirm COPD diagnosis 1. If these values were obtained pre-bronchodilator only, you must repeat testing post-bronchodilator to:

• Rule out "flow responders" who may show FEV1/FVC ≥0.7 after bronchodilation
• Avoid missing "volume responders" who may only show obstruction post-bronchodilator
• Ensure accurate diagnosis before committing to long-term treatment 1

Critical caveat: The relatively preserved FVC (82%) with reduced FEV1 (55%) suggests predominant airway obstruction rather than restrictive disease. However, values close to diagnostic thresholds should be repeated to confirm accuracy 1.

COPD Severity Classification

With FEV1 at 55% predicted, this represents GOLD Grade 2 (Moderate) airflow limitation 2. This severity level typically requires:

• Regular bronchodilator therapy (long-acting preferred)
• Assessment of symptom burden and exacerbation history
• Pulmonary rehabilitation referral consideration
• Smoking cessation if actively smoking (most critical intervention)

Clinical Correlation Required

The diagnosis requires more than just spirometry numbers. You must document:

• Chronic respiratory symptoms: dyspnea, chronic cough, sputum production
• Risk factor exposure: smoking history (pack-years), occupational exposures, biomass fuel
• Exclusion of alternative diagnoses: particularly asthma, which can show similar spirometry 3

Important distinction: Research shows that using FEV1/FVC <0.7 alone without considering low FEV1 (<80% predicted) may lead to overdiagnosis 4. However, your patient has BOTH criteria (FEV1/FVC <0.7 AND FEV1 <80%), which strongly associates with clinically meaningful COPD and adverse outcomes 4.

Management Algorithm

1. Confirm post-bronchodilator values if not already done 1
2. Assess symptom burden using validated tools (mMRC or CAT score)
3. Document exacerbation history (frequency and severity in past year)
4. Initiate pharmacotherapy:
   • Long-acting bronchodilator (LABA or LAMA) as first-line
   • Consider combination therapy based on symptoms/exacerbations
5. Smoking cessation if applicable (most impactful intervention for disease progression)
6. Pulmonary rehabilitation referral
7. Vaccinations: influenza annually, pneumococcal, COVID-19

Common Pitfalls to Avoid

• Don't diagnose COPD on pre-bronchodilator spirometry alone - this can overdiagnose by up to 36% 1
• Don't ignore the clinical context - spirometry alone without symptoms/exposure may represent false positive 2
• Don't confuse with asthma - the lack of significant bronchodilator response helps distinguish COPD, but overlap exists 3
• Don't use fixed ratio in very young or very old patients without considering lower limit of normal - though at typical COPD age ranges (>40 years), the fixed ratio is appropriate 4

The combination of FEV1/FVC <0.7 with FEV1 55% predicted provides strong evidence for clinically significant COPD requiring treatment 4, 5.